Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis.

Author: LiuY, QiuP, WangG-L, WenJ-B, WenP, XiaoX-Z, XuL-F, ZhouS-F

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To evaluate the cost-effectiveness of lamivudine (LMV), telbivudine (LdT), adefovir dipivoxil (ADV) and entecavir (ETV) on decompensated hepatitis B virus-related cirrhosis. PATIENTS AND METHODS: 1332 patients with decompensated hepatitis B virus-related cirrhosis were randomly assigned ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/27010143

データ提供:米国国立医学図書館(NLM)

Navigating the Desert of Hepatitis B: Cost-Effective Treatment Options

Hepatitis B, a viral infection that can lead to cirrhosis, is like a treacherous desert. This study, like a knowledgeable guide, helps us understand the best routes for treating decompensated hepatitis B virus-related cirrhosis.

The researchers compared the cost-effectiveness of five different treatment plans for hepatitis B cirrhosis: lamivudine (LMV), telbivudine (LdT), adefovir dipivoxil (ADV), LMV+ADV, and entecavir (ETV). The study, like a map showing different paths through the desert, shows that LMV+ADV and ETV were the most effective in improving liver function and suppressing viral replication.

The study also compared the cost-effectiveness of each treatment plan. Entacavir (ETV) emerged as the most cost-effective option, while LMV+ADV was a good alternative. This is like finding the most efficient and affordable way to travel through the desert, maximizing resources and minimizing expenses.

The Most Cost-Effective Path

The study found that ETV was the most cost-effective option, followed by LMV+ADV. This is like finding the most efficient route through the desert, using the least amount of resources while still achieving your goal.

Navigating the Desert of Hepatitis B

The desert of hepatitis B can be daunting, but this study offers valuable insights into managing this condition. By understanding the cost-effectiveness of various treatment options, healthcare providers can make informed decisions to optimize patient care and minimize financial burden. This is like choosing the right camel for the journey, ensuring that you have the right resources to navigate the desert safely and efficiently.

Dr.Camel's Conclusion

This research provides a comprehensive overview of cost-effective treatment options for decompensated hepatitis B virus-related cirrhosis. It emphasizes the importance of balancing effectiveness and cost, guiding healthcare providers towards the best paths for patient care. It's like finding the perfect balance between speed and efficiency in the desert, ensuring a successful and safe journey.

Date :
  1. Date Completed 2016-11-11
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

27010143

DOI: Digital Object Identifier

27010143

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.